CIK 0001752828 · <br>Emerging growth company
Celularity Inc
Sign in to watch- Ticker
- CELU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831702591
- Phone
- (908) 768-2170
- Business address
- 170 PARK AVE, FLORHAM PARK, NJ, 07932
- Former names
- GX Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-13 | Haines John R See Remarks | Shares withheld for taxes | −5,770 | $0.71 | $4K | 459,847 |
| 2023-04-13 | Glover Bradley See Remarks | Shares withheld for taxes | −2,884 | $0.71 | $2K | 351,192 |
| 2023-03-27 | Hariri Robert J Chief Executive Officer | Grant or award | +2,084,854 | $0.83 | $1.7M | 10,159,850 |
| 2023-03-27 | Hariri Robert J Chief Executive Officer | Grant or award · Warrants (Right to Buy) | −2,084,854 | 2,084,854 | ||
| 2023-03-15 | Fletcher Kyle See Remarks | Shares withheld for taxes | −2,170 | $0.63 | $1K | 257,000 |
| 2023-02-17 | Fletcher Kyle See Remarks | Grant or award | +225,000 | 259,170 | ||
| 2023-02-17 | Haines John R Senior Exec Vice President | Grant or award | +400,000 | 465,617 | ||
| 2023-02-17 | Beers David C Chief Financial Officer | Grant or award | +250,000 | 291,011 | ||
| 2023-02-17 | Glover Bradley See Remarks | Grant or award | +300,000 | 354,076 | ||
| 2023-02-17 | Brigido Stephen Pres, Functional Regeneration | Grant or award | +200,000 | 232,809 | ||
| 2023-02-17 | Kilcoyne Adrian Chief Medical Officer | Grant or award | +300,000 | 300,000 | ||
| 2023-02-10 | Diamandis Peter Director | Option exercise | +1,071,000 | $0.28 | $300K | 1,107,145 |
| 2023-02-10 | Diamandis Peter Director | Option exercise · Stock Option (Right to Buy) | −1,071,000 | 2,660,136 | ||
| 2022-11-30 | Hariri Robert J Chief Executive Officer | Purchase | +10,000 | $1.72 | $17K | 8,074,996 |
| 2022-11-29 | Hariri Robert J Chief Executive Officer | Purchase | +40,000 | $1.71 | $68K | 8,064,996 |
| 2022-11-28 | Hariri Robert J Chief Executive Officer | Purchase | +40,000 | $1.74 | $70K | 8,024,996 |
| 2022-11-16 | Jones Anne Chief Business Officer | Shares withheld for taxes | −3,734 | $1.89 | $7K | 49,154 |
| 2022-11-16 | Fletcher Kyle General Counsel | Shares withheld for taxes | −1,262 | $1.89 | $2K | 34,170 |
| 2022-10-03 | Kilcoyne Adrian See Remarks | Grant or award · Stock Option (Right to Buy) | +66,226 | 66,226 | ||
| 2022-08-26 | SCULLEY JOHN Director | Option exercise | +768,594 | $0.28 | $215K | 804,739 |
Page 9 of 15 · 299 trades